DEA Clarifies Exemption for Sales of Pseudoephedrine and Phenylpropanolamine Products by Retail Distributors

Summary

The US Drug Enforcement Administration (DEA) has issued an interpretive rule to provide guidance to retail distributors on complying with the law and DEA regulations regarding the exemption of sales of pseudoephedrine and phenylpropanolamine products, commonly found in over-the-counter cold and allergy medications.